论文部分内容阅读
目的:了解我院呼吸科哮喘病人治疗药物的使用情况。方法:随机抽查我院呼吸科2001年诊断为哮喘的病历100份,采用WHO推荐的限定日剂量(DDD)和药物利用指数(DUI)为判断标准,对哮喘患者用药情况进行分析。结果:药物使用频率排在前10位的依次为茶碱、班布特罗、标准桃金娘油、缓释茶碱、丙卡特罗、地塞米松、异丙托溴铵、沙丁胺醇、酮替芬、扎鲁司特。从每日费用看,排在前5位的依次为甲基泼尼松龙、异丙托溴铵、沙丁胺醇、扎鲁司特、标准桃金娘油。结论:我院治疗哮喘用药基本合理,没有滥用。
Objective: To understand the use of drugs for treatment of respiratory asthma in our hospital. Methods: A total of 100 cases of asthma diagnosed in our department of respiratory medicine in 2001 were randomly selected. The DDD and DUI criteria recommended by the WHO were used as criteria to analyze the medication status of patients with asthma. Results: The top 10 most frequently used drugs were theophylline, bambuterol, standard myrtle oil, sustained release theophylline, procaterol, dexamethasone, ipratropium bromide, salbutamol, keto Fen, Zarroute. From the daily cost, top 5 in order were methylprednisolone, ipratropium bromide, salbutamol, zafirlukast, standard myrtle oil. Conclusion: The treatment of asthma in our hospital basically reasonable, there is no abuse.